The European Council has adopted a new drug strategy to address rising risks from synthetic drugs and combat drug use and trafficking. The framework focuses on security, health, and social challenges, with member states set to discuss the issue at an upcoming summit.
The new EU drug strategy represents a significant coordinated effort to tackle the escalating drug problem across member states, addressing both the supply and demand sides of illicit substances and their impact on public health and security.
The European Council has approved its first-ever drug framework aimed at reducing drug use and drug-related crimes across the European Union. This ambitious strategy responds to growing concerns over drug consumption and trafficking, with the European Union Drugs Agency reporting at least 7,600 annual overdose deaths. Synthetic drug trafficking has surged by over 1,000 percent in the past decade, prompting organized crime networks to adapt by rerouting cocaine shipments to secondary ports. The new framework, adopted by unanimous political consensus, mandates major EU maritime ports to form alliances and coordinate efforts. It also targets the financing of trafficking operations and seeks to curb synthetic drug production through legal bans on certain chemicals. On the health front, the strategy proposes implementing city-level tracking networks, distributing take-home overdose reversal medications, and funding integrated treatment models for vulnerable populations.